Lichen Sclerosus Treatment Market

Lichen sclerosus is a chronic disorder of the skin, affecting the genital and anal areas. However, in some serious cases, they may appear on upper body such as arms and breast regions. According to various studies, lichen sclerosus is most common in females (after menopause), uncommon in adult males, and very rare in children. Lichen sclerosus appears by forming white spots on the affected regions, the spots may be glossy and smooth in appearance, if untreated they develop into bigger patches. In addition, lichen sclerosus may result in red or purple colored bruises, skin becomes more prone to tear, itching and bleeding. The main cause of lichen sclerosus is still unknown, it is believed to be caused by hyper-immunity reactions or by hormonal imbalance. An individual with previous skin destruction around genital or anal region, are more susceptible to develop lichen sclerosus. Corticosteroids are mainly used for the treatment and management of lichen sclerosus. Women with vulva?s lichen sclerosus are at a high risk of causing vulvar cancer.
Lichen Sclerosus Treatment Market contains market size and forecasts of Lichen Sclerosus Treatment in Global, including the following market information:
Global Lichen Sclerosus Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lichen Sclerosus Treatment market was valued at 97 million in 2021 and is projected to reach US$ 129.5 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lichen Sclerosus Treatment include GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, AstraZeneca, Sandoz AG (Novartis AG), Sanofi S.A, Bristol-Myers Squibb Company and Bausch Health and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lichen Sclerosus Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lichen Sclerosus Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lichen Sclerosus Treatment Market Segment Percentages, by Type, 2021 (%)
Topical
Oral
Injection
Others
Global Lichen Sclerosus Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lichen Sclerosus Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Clinics
Retail Pharmacies
Online Pharmacies
Others
Global Lichen Sclerosus Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lichen Sclerosus Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lichen Sclerosus Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lichen Sclerosus Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Sandoz AG (Novartis AG)
Sanofi S.A
Bristol-Myers Squibb Company
Bausch Health
Zylera Pharmaceuticals